Bal Pharma Ltd Share Price
(BALPHARMA)
₹106.41▲0.44%
as on 04:01PM, 16 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 30.21 % |
3 Month Return | -9.1 % |
1 Year Return | + 7.72 % |
Market Stats | |
Previous Close | ₹105.94 |
Open | ₹106.00 |
Volume | 27.84K |
Upper Circuit | ₹116.53 |
Lower Circuit | ₹95.34 |
Market Cap | ₹168.67Cr |
P/E Ratio
21.75
PEG Ratio
8.3
Market Cap
₹168.67 Cr
P/B Ratio
1.37
EPS
4.71
Dividend Yield
1.31
Sector
Pharmaceuticals
ROE
10.19
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, BALPHARMA stock has moved up by 30.2%
Revenue Rich
Revenue is up for the last 2 quarters, 73.49 Cr → 73.66 Cr (in ₹), with an average increase of 0.2% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.86% of holdings in Mar 2025 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 49.00% of holdings in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 52.3% return, outperforming this stock by 44.6%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.14% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.8% return, outperforming this stock by 132.8%
Profit Down
Netprofit is down for the last 2 quarters, 1.04 Cr → 0.48 Cr (in ₹), with an average decrease of 53.9% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 50.86% | 0.00 | |
Foreign Institutions | 0.14% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 49% | 0.00 | |
Others | 0% | 0.00 |
Bal Pharma Ltd in the last 5 years
Lowest (-535.88x)
June 15, 2018
Today (21.75x)
April 15, 2025
Industry (51.72x)
April 15, 2025
Highest (203.65x)
September 12, 2018
Bal Pharma Ltd’s net profit fell -46.07% since last year same period to ₹0.48Cr in the Q3 2024-2025. On a quarterly growth basis, Bal Pharma Ltd has generated -53.85% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Bal Pharma Ltd has declared dividend of ₹1.20 - translating a dividend yield of 2.08%.
Read More about DividendsBearish
Neutral
Bullish
Bal Pharma Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹168.67 Cr | 22.5% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹71.63 Cr | 96.86% | 0.80 | NA | NA | |
NA | ₹60.19 Cr | 4.03% | 0.78 | ₹2 Cr | ₹45 Cr | |
NA | ₹832.63 Cr | 188.69% | 0.91 | ₹55 Cr | ₹575 Cr | |
NA | ₹369.67 Cr | 70.49% | 0.56 | -₹3 Cr | ₹241 Cr |
Organisation | Bal Pharma Ltd |
Headquarters | Bangalore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Bal Pharma Ltd share price today stands at ₹106.41, Open: ₹106, Previous Close: ₹105.94, High: ₹108.6, Low: ₹105.99, 52 Week High: ₹157.98, 52 Week Low: ₹78.06.
Today's traded volume of Bal Pharma Ltd(BALPHARMA) is 27.84K.
Today's market capitalisation of Bal Pharma Ltd(BALPHARMA) is ₹168.67Cr.
Bal Pharma Ltd (BALPHARMA) share price is ₹106.41. It is down -32.64% from its 52 Week High price of ₹157.98
Bal Pharma Ltd (BALPHARMA) share price is ₹106.41. It is up 36.32% from its 52 Week Low price of ₹78.06